Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
29
-
Total 13F shares, excl. options
-
14,665,251
-
Shares change
-
+2,911,488
-
Total reported value, excl. options
-
$4,836,180
-
Value change
-
+$959,017
-
Number of buys
-
16
-
Number of sells
-
-3
-
Price
-
$0.3298
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q4 2024
30 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q4 2024.
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) has 29 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14,665,251 shares
.
Largest 10 shareholders include BlackRock, Inc. (5,896,899 shares), GEODE CAPITAL MANAGEMENT, LLC (1,971,894 shares), UBS Group AG (1,770,080 shares), JANE STREET GROUP, LLC (1,662,682 shares), Point72 Asset Management, L.P. (1,596,344 shares), NORTHERN TRUST CORP (489,735 shares), MILLENNIUM MANAGEMENT LLC (284,123 shares), PFG Investments, LLC (218,003 shares), TWO SIGMA INVESTMENTS, LP (200,797 shares), and COMMONWEALTH EQUITY SERVICES, LLC (120,292 shares).
This table shows the top 29 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.